Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2005 | |
| Cash Flows From Operating Activities | |
| Net Income | -19,972 |
| Depreciation Amortization | 668 |
| Other Working Capital | 788 |
| Other Operating Activity | 392 |
| Operating Cash Flow | $-18,124 |
| Cash Flows From Investing Activities | |
| Change In Deposits | -13,897 |
| PPE Investments | -3,041 |
| Investing Cash Flow | $-16,938 |
| Cash Flows From Financing Activities | |
| Debt Issued | 1,112 |
| Debt Repayment | -273 |
| Common Stock Issued | 99 |
| Other Financing Activity | 40,316 |
| Financing Cash Flow | $41,254 |
| Beginning Cash Position | 257 |
| End Cash Position | 6,449 |
| Net Cash Flow | $6,192 |
| Free Cash Flow | |
| Operating Cash Flow | -18,124 |
| Capital Expenditure | -3,041 |
| Free Cash Flow | -21,165 |